Centre Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $9.41M | Sell |
371,257
-26,233
| -7% | -$686K | 2.42% | 11 |
|
|
2024
Q4 | $10.5M | Sell |
397,490
-35,424
| -8% | -$961K | 2.41% | 15 |
|
|
2024
Q3 | $12.5M | Buy |
+432,914
| New | +$12.6M | 2.7% | 13 |
|
|
2023
Q3 | – | Sell |
-65,718
| Closed | -$2.41M | – | 79 |
|
|
2023
Q2 | $2.41M | Buy |
65,718
+1,682
| +3% | +$65.5K | 0.53% | 55 |
|
|
2023
Q1 | $2.61M | Buy |
64,036
+1,004
| +2% | +$43.4K | 0.63% | 54 |
|
|
2022
Q4 | $3.23M | Buy |
63,032
+1,891
| +3% | +$90.7K | 0.86% | 45 |
|
|
2022
Q3 | $2.68M | Sell |
61,141
-32
| -0.1% | -$1.55K | 0.74% | 44 |
|
|
2022
Q2 | $3.21M | Buy |
+61,173
| New | +$3.12M | 0.85% | 37 |
|
|
2019
Q4 | – | Sell |
-419,664
| Closed | -$14.3M | – | 71 |
|
|
2019
Q3 | $14.3M | Buy |
419,664
+213,562
| +104% | +$7.77M | 3.3% | 12 |
|
|
2019
Q2 | $8.47M | Buy |
206,102
+13,557
| +7% | +$538K | 2.04% | 21 |
|
|
2019
Q1 | $7.76M | Buy |
192,545
+6,556
| +4% | +$263K | 2.02% | 18 |
|
|
2018
Q4 | $7.7M | Buy |
+185,989
| New | +$7.72M | 2.27% | 16 |
|
|
2018
Q3 | – | Sell |
-224,576
| Closed | -$7.73M | – | 75 |
|
|
2018
Q2 | $7.73M | Buy |
+224,576
| New | +$7.67M | 1.81% | 19 |
|
|
2017
Q2 | – | Sell |
-123,940
| Closed | -$4.02M | – | 52 |
|
|
2017
Q1 | $4.02M | Sell |
123,940
-51,783
| -29% | -$1.63M | 1.1% | 44 |
|
|
2016
Q4 | $5.42M | Sell |
175,723
-94,544
| -35% | -$2.89M | 1.05% | 45 |
|
|
2016
Q3 | $8.69M | Sell |
270,267
-23,377
| -8% | -$782K | 1.58% | 28 |
|
|
2016
Q2 | $9.81M | Buy |
293,644
+64,062
| +28% | +$2.04M | 1.74% | 25 |
|
|
2016
Q1 | $6.46M | Sell |
229,582
-2,867
| -1% | -$81.9K | 1.12% | 39 |
|
|
2015
Q4 | $7.12M | Buy |
232,449
+202,579
| +678% | +$6.37M | 1.22% | 39 |
|
|
2015
Q3 | $890K | Sell |
29,870
-50,071
| -63% | -$1.61M | 0.15% | 57 |
|
|
2015
Q2 | $2.54M | Buy |
79,941
+3,837
| +5% | +$125K | 0.4% | 59 |
|
|
2015
Q1 | $2.51M | Buy |
76,104
+60,926
| +401% | +$1.94M | 0.37% | 58 |
|
|
2014
Q4 | $449K | Sell |
15,178
-224,481
| -94% | -$6.44M | 0.07% | 94 |
|
|
2014
Q3 | $6.72M | Sell |
239,659
-51,010
| -18% | -$1.43M | 1.03% | 42 |
|
|
2014
Q2 | $8.19M | Sell |
290,669
-171,085
| -37% | -$4.88M | 1.23% | 30 |
|
|
2014
Q1 | $14.1M | Buy |
461,754
+147,718
| +47% | +$4.4M | 2.08% | 8 |
|
|
2013
Q4 | $9.13M | Sell |
314,036
-115,318
| -27% | -$3.36M | 1.41% | 29 |
|
|
2013
Q3 | $11.7M | Buy |
429,354
+70,902
| +20% | +$1.93M | 1.86% | 16 |
|
|
2013
Q2 | $9.53M | Buy |
+358,452
| New | +$9.9M | 1.55% | 21 |
|
Other funds holding PFE
TIM
Centre Asset Management's PFE Position: Q1 2025 in Review
Centre Asset Management reduced its Pfizer (PFE) stake by 6.6% in Q1 2025, selling an estimated $686K and leaving 371,257 shares worth $9.41M. The position accounts for 2.42% of the portfolio, ranked #11.
Centre Asset Management first reported a position in PFE in Q2 2013 and has held it in 29 quarters since. The position peaked at $14.3M in Q3 2019. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- Centre Asset Management held 371,257 shares of Pfizer worth $9.41M as of Q1 2025.
- Centre Asset Management sold 26,233 Pfizer shares in Q1 2025, an estimated $686K.
- Pfizer made up 2.42% of Centre Asset Management's portfolio in Q1 2025, its #11 holding.
- Centre Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 29 quarters since.
- Centre Asset Management's Pfizer position peaked at $14.3M in Q3 2019.
- 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on Centre Asset Management's 13F filing for Q1 2025, filed 1 Apr 2025.